Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,2013,220 of 20,252 grants

Active TRAINING, INDIVIDUAL
Deciphering the functional role of recurrent PPP2R1A mutations on endometrial metastasis
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2026

Project Summary: Uterine serous carcinomas (USC), uterine carcinosarcomas (UCS), and leiomyosarcomas represent the most aggressive subtypes of uterine cancer and account for a disp...

$421.1K
USD
Completed TRAINING, INDIVIDUAL
Examining the impact of laboratory housing temperature on murine CD28 and the response to anti-PD-1
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2023 – 2025

Project Abstract/Summary For decades, animals in biomedical research have yielded significant scientific and medical breakthroughs by generating the essential preclinical data that...

$367.9K
USD
Completed SBIR-STTR RPGS
Development of a novel small molecule RPN13 inhibitor and therapeutic for advanced ovarian cancer patients
NATIONAL CANCER INSTITUTE Up Therapeutics, Inc United States 2023 – 2025

Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy despite aggressive surgery and toxic chemotherapies. More effective and safer targeted drugs are urgentl...

$11.79M
USD
Active NON-SBIR/STTR RPGS
The PLOD2/succinate axis in cancer cell plasticity and stemness
NATIONAL CANCER INSTITUTE University of Kentucky United States 2023 – 2028

Abstract Tumor cells in TNBC tissue exhibit enhanced cell plasticity and stemness, which is crucial for cancer metastasis. Metabolic and epigenetic reprogramming plays crucial role...

$3.47M
USD
Active RESEARCH CENTERS
DF/HCC Prostate SPORE
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

PROJECT SUMMARY – OVERALL The Dana-Farber/Harvard Cancer Center (DF/HCC) Prostate SPORE seeks to improve the understanding and treatment of prostate cancer using a highly translati...

$23.94M
USD
Active RESEARCH CENTERS
DF/HCC Prostate SPORE
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

PROJECT SUMMARY – ADMINISTRATIVE CORE (CORE A) The DF/HCC Prostate SPORE Administrative Core (Core A) is instrumental for the overall function and success of the Prostate SPORE pro...

Active RESEARCH CENTERS
Efficacy and Mechanisms of Resistance to Neoadjuvant Intensive Androgen Signaling Inhibition
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

PROJECT SUMMARY – PROJECT 1 Localized high-risk prostate cancer (PCa) comprises ~15% of newly diagnosed localized PCa, and the cure rate for these tumors after primary surgical tre...

Active RESEARCH CENTERS
Career Enhancement Program
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

PROJECT SUMMARY – CAREER ENHANCEMENT PROGRAM (CEP) The goal of the DF/HCC Prostate SPORE Career Enhancement Program (CEP) is to provide resources, financial support, and mentorship...

Active NON-SBIR/STTR RPGS
Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

Abstract/Summary Among the Epstein-Barr virus associated cancers is post-transplant lymphoproliferative disease (PTLD), a rare but major complication of pediatric solid organ trans...

$9.46M
USD
Active NON-SBIR/STTR RPGS
Epigenetic dependence of diffuse midline glioma with H3K27M mutation
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

Diffuse intrinsic pontine glioma (DIPG) is a deadly disease with the median survival of DIPG patients less than one year after diagnosis. DIPG tumors initiate from the pons and mid...

$4.46M
USD
Active NON-SBIR/STTR RPGS
Modeling and Dissecting Epigenetic Drivers of Gliomagenesis
NATIONAL CANCER INSTITUTE State University New York Stony Brook United States 2023 – 2026

PROJECT SUMMARY Diffuse gliomas are incurable brain tumors despite aggressive therapies 1–4. Understanding the mechanisms that initiate gliomas is a critical step towards improving...

$1.9M
USD
Active NON-SBIR/STTR RPGS
Systematic Characterization of Small Nucleolar RNAs in Cancer
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2023 – 2026

Abstract Despite recent advancements in treatment options for cancer, a majority of cancer types continue to lack fully characterized and effective targeted therapies. This insuffi...

$3.87M
USD
Active NON-SBIR/STTR RPGS
Roles of LMP1 and MYC in EBV-induced B-cell tumors
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Epstein-Barr virus (EBV) is an important cause of human lymphomas in both immunocompetent and immunosuppressed humans, including Burkitt lymphomas (BLs), H...

$4.51M
USD
Active NON-SBIR/STTR RPGS
Inferring Kinase Activity from Tumor Phosphoproteomic Data
NATIONAL CANCER INSTITUTE University of Virginia United States 2023 – 2026

Project Summary Kinases are fundamentally important enzymes for regulating cell physiology through regulation of proteins and protein interactions by phosphorylating tyrosine, seri...

$3.69M
USD
Active OTHER RESEARCH-RELATED
GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management
NATIONAL CANCER INSTITUTE University of Utah United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Evidence supports individualizing risk-stratified cancer screening, with selective application of specific screening interventions best suited to the indiv...

$7.4M
USD
Completed TRAINING, INDIVIDUAL
Identifying genetic vulnerabilities in KIAA1549-BRAF mutant pediatric low-grade gliomas
NATIONAL CANCER INSTITUTE Broad Institute, Inc United States 2023 – 2025

Project Summary: Pediatric low-grade gliomas (pLGGs) typically harbor only a single oncogenic driver event which almost universally result in MAPK pathway activation. The most freq...

$788.9K
USD
Active OTHER RESEARCH-RELATED
Fertility legislation and unmet needs: Exploring intervenable barriers for quality oncofertility care among adolescent and young adult cancer patients
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Curative cancer treatment modalities (e.g., chemotherapy) are gonadotoxic (i.e., destroy sperm and eggs) and frequently cause infertility. Thus, clinical p...

$992.2K
USD
Active NON-SBIR/STTR RPGS
Metabolism of cancer chemotherapeutics by the human gut microbiome
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2028

PROJECT SUMMARY – NO CHANGES FROM PARENT GRANT Rigorous data from our lab and others indicate that the gut microbiome may an underappreciated contributor to inter-individual variat...

$1.31M
USD
Active NON-SBIR/STTR RPGS
Cancer misinformation on social media and its correction
NATIONAL CANCER INSTITUTE Northeastern University United States 2023 – 2026

Project Summary The overarching goal of this study is to measure the prevalence of cancer misinformation on social media and understand the mechanisms that underlies its spread. Be...

$2.45M
USD
Active OTHER RESEARCH-RELATED
Cell-free DNA Analysis for Liquid Biopsy of Cancer
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2027

PROJECT SUMMARY/ABSTRACT Circulating tumor DNA (ctDNA) which mirrors the parental tumor, is present in the plasma of non-small cell lung carcinoma (NSCLC) patients. Liquid biopsy a...

$964.7K
USD